Most cited papers from Oncomatryx (Spain)

Oncomatryx (Spain)

What are the most cited papers from Oncomatryx (Spain)?

The most cited paper from Oncomatryx (Spain) is "Overexpression of COL11A1 by Cancer-Associated Fibroblasts: Clinical Relevance of a Stromal Marker in Pancreatic Cancer" (Carmen García-Pravia, José A. Galván, Natalia Gutiérrez-Corral et al., 2013), with 97 citations. Next come "Collagen, type XI, alpha 1: An accurate marker for differential diagnosis of breast carcinoma invasiveness in core needle biopsies" (27) and "In vitro and in vivo activity of a new small-molecule inhibitor of HDAC6 in mantle cell lymphoma" (20).

Published FieldAccess

Showing 10 of 10 papers. Every paper is listed.

Most cited papers, sortable by citations and release date
#	Paper
1	Overexpression of COL11A1 by Cancer-Associated Fibroblasts: Clinical Relevance of a Stromal Marker in Pancreatic Cancer Carmen García-Pravia, José A. Galván, Natalia Gutiérrez-Corral et al. · PLoS ONE Open access	23 Oct 2013	97
2	Collagen, type XI, alpha 1: An accurate marker for differential diagnosis of breast carcinoma invasiveness in core needle biopsies Javier Freire, Saioa Domínguez-Hormaetxe, Saray Pereda et al. · Pathology - Research and Practice	8 Aug 2014	27
3	In vitro and in vivo activity of a new small-molecule inhibitor of HDAC6 in mantle cell lymphoma Montserrat Pérez-Salvia et al. · Haematologica Open access	7 Jun 2018	20
4	Targeting carcinoma‐associated mesothelial cells with antibody–drug conjugates in ovarian carcinomatosis Lucía Pascual‐Antón, Pilar Sandoval, Guadalupe Tirma Gónzalez-Mateo et al. · The Journal of Pathology Open access	9 Aug 2023	16
5	Expression of Epithelial and Mesenchymal Markers in Plasmatic Extracellular Vesicles as a Diagnostic Tool for Neoplastic Processes Begoña Otero‐Alén, Lara Sofía Estévez-Pérez, María Otero-Alén et al. · International Journal of Molecular Sciences Open access	10 Feb 2023	7
6	Simultaneous Detection of Collagen I Alpha II and Cytokeratin 19 mRNA by Multiplex qPCR in Liquid Biopsy in Diagnosis of Patients with Resectable Solid Tumors Lara Sofía Estévez Pérez, Begoña Otero‐Alén, María Otero-Alén et al. · International Journal of Molecular Sciences Open access	3 Sep 2024	2
7	The FAP × CD3 bispecific antibody OMTX305 induces T cell–mediated antitumor effects in patient-derived ex vivo models of solid tumors Julia Thiel, Jan A. Schlegel, Chunguang Liang et al. · Science Advances Open access	11 Sep 2026	0
8	2250P Cancer-associated fibroblast biomarkers to unravel the mechanism of action and tentative patient stratification for OMTX705, a CAF-targeted antibody-drug conjugate Amparo Ruı́z, Alvaro J González, Pedro Luis Sosa Gonzalez et al. · Annals of Oncology Open access	Sep 2025	0
9	Tumour stroma targeting and modulation by OMTX705 ADC, a novel and potent immunotherapeutic treatment of solid tumours Myriam Fabre, Cristina Suárez Ferrer, Saioa Domínguez-Hormaetxe et al. · Annals of Oncology Open access	Oct 2019	0
10	OMTX705, a powerful stroma-targeting ADC to treat invasive tumors with low response to immunotherapeutic anti-PD-1 treatments Myriam Fabre, Cristina Suárez Ferrer, Saioa Domínguez-Hormaetxe et al. · Annals of Oncology Open access	Oct 2018	0

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.